Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2026-01-24 @ 10:57 PM
Study NCT ID:
NCT00401635
Status:
COMPLETED
Last Update Posted:
2007-09-05
First Post:
2006-11-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal Doxorubicin
Sponsor:
National Cancer Institute, Naples
Organization: